𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Alterations of the Sphingolipid Pathway in Alzheimer’s Disease: New Biomarkers and Treatment Targets?

✍ Scribed by Michelle M. Mielke; Constantine G. Lyketsos

Book ID
107568667
Publisher
Humana Press Inc
Year
2010
Tongue
English
Weight
287 KB
Volume
12
Category
Article
ISSN
1535-1084

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tetrahydroaminoacridine and lecithin in
Tetrahydroaminoacridine and lecithin in the treatment of Alzheimer's disease
✍ Henry C. Weinstein; Saskia Teunisse; Willem A. Gool 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 529 KB

In 12 ambulant patients with a clinical diagnosis of probable Alzheimer's disease, a 12-week, double-blind, placebo-controlled study with 100 mg/day tetrahydroaminoacridine (THA) and 10 g/day lecithin is reported. The aim of the study was to find whether treatment would result in an improvement of c